Targeting Medulloblastoma: Small-Molecule Inhibitors of the Sonic Hedgehog Pathway as Potential Cancer Therapeutics
- 15 June 2005
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (12) , 4975-4978
- https://doi.org/10.1158/0008-5472.can-05-0481
Abstract
Medulloblastoma is the most common malignant pediatric brain tumor for which no satisfactory treatments exist. The Sonic Hedgehog signaling pathway seems to play an important role in the pathology of this disease. Here we review our recent demonstration that a small-molecule inhibitor of this pathway can regress tumors that arise in a transgenic mouse model of medulloblastoma. These and other findings suggest that inhibitors of Sonic Hedgehog signaling may offer an effective way to target some malignancies.Keywords
This publication has 17 references indexed in Scilit:
- Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− miceCancer Cell, 2004
- Deregulation of Dorsoventral Patterning by FGF Confers Trilineage Differentiation Capacity on CNS Stem Cells In VitroNeuron, 2003
- Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumoursNature, 2003
- Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancerNature, 2003
- Inhibition of Hedgehog signaling by direct binding of cyclopamine to SmoothenedGenes & Development, 2002
- Medulloblastoma Growth Inhibition by Hedgehog Pathway BlockadeScience, 2002
- Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumoursOncogene, 1997
- Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndromeAmerican Journal of Medical Genetics, 1997
- Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma SyndromePublished by Elsevier ,1996
- Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus SyndromeScience, 1996